Dr. Arthur Mikaelian, becomes Quanta's Chief Science Officer and is named to the Board of Directors
LOS ANGELES, June 21, 2019 /PRNewswire/ -- Quanta, Inc. (OTC: QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, announced today that Dr. Arthur Mikaelian, founder of the patented polarization technology utilized by Quanta, has officially become the companies' Chief Science Officer.
Dr. Arthur Mikaelian will be focused on leading Quanta's science team in further enhancing the quality of all Quanta products by increasing the bioactivity of all ingredients used in Quanta formulations. Dr. Arthur Mikaelian will also have a key role in the development of products to help combat common ailments in the fields of; sleep disorder, cognitive function, sexual performance, tumor reduction, and many more.
Dr. Mikaelian commented saying, "My goal is to make this a company that provides evidence-based alternative wellness products." He continued to say, "Rather than being based on positive testimonials, we will be backed by evidence and science. To my knowledge, we are currently the only company that can alter the molecular activity in cannabinoids, giving them a new and distinguishable quality."
With Dr. Mikaelian joining in a full-time capacity, Quanta becomes a company rooted in research-based proof. When asked why Dr. Mikaelian ultimately decided to join Quanta as Chief Science Officer, he stated, "My scientific approach is to create a scientific breach between alternative and conventional medicine. Quanta gives me a fantastic platform to create products that are made naturally without synthetics and are truly impactful. This aligns perfectly with my personal vision."
SOURCE Quanta, Inc.
Company Codes: OTC-PINK:QNTA